Canadian Respiratory Journal / 2016 / Article / Tab 3

Research Article

The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario

Table 3

Average health service utilization costs per month among individuals receiving PAH therapy in the Survivor Cohort and the Deceased Cohort, in Ontario, from April 1, 2011, to March 31, 2012.

Survivor CohortDeceased Cohort value
Overall ()Overall ()

Overall cost for health services utilization
 Median (IQR)264 (96747)2,021 (9936,399) <0.001
 Mean (SD)751 (1,461)4,669 (6,551)<0.001
Physician visits
 Number with any physician visits ( (%))290 (99.3%)34 (100%)0.628
 Number of physician visits (median (IQR))28 (17–46)31.5 (16–46)0.886
 Costs of physician visits (median (IQR))160 (87275)551 (301769)<0.001
 Number with any hospitalizations ( (%))144 (49.3%)28 (82.4%)<0.001
 Number of hospitalizations (median (IQR))1.5 (1-2)1 (1-2)0.766
 Costs of hospitalizations (median (IQR))405 (152889)1,820 (7676,332)<0.001
Emergency department visits
 Number with any emergency department visits ( (%))144 (49.3%)31 (91.2%)<0.001
 Number of emergency department visits (median (IQR))2 (1–4)2 (1–3)0.922
 Costs of emergency department visits (median (IQR))62 (26119)213 (101392)<0.001

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.